More claims about depression, immune function, and survival that exceed the evidence [5]

Journal of Clinical Oncology

Volumn 25, Issue 33, 2007, Pages 5328-5329

  Coyne, James C ^a   Palmer, Steven C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

BREAST CANCER; CANCER CENTER; CANCER SURVIVAL; CELL COUNT; CELL SURVIVAL; DISEASE COURSE; DRUG EFFICACY; HEALTH STATUS; HUMAN; IMMUNE FUNCTION TEST; IMMUNE SYSTEM; LETTER; MAJOR DEPRESSION; MORTALITY; NATURAL KILLER CELL; PATIENT INFORMATION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE;

CARCINOMA, HEPATOCELLULAR; DEPRESSION; HUMANS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MOOD DISORDERS;

EID: 36849064178     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.8594     Document Type: Letter

References (11)

1. Cameron LD, Booth RJ, Schlatter M, et al: Cognitive and affective determinants of decisions to attend a group psychosocial support program for women with breast cancer. Psychosom Med 67:584-589, 2005
2. Steel JL, Geller DA, Gamblin TC, et al: Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol 25:2397-2405, 2007
3. Irwin MR: Depression and Risk of Cancer Progression: An Elusive Link. J Clin Oncol 2007; 25:2343-2344, 2007
4. Fechner-Bates S, Coyne JC, Schwenk TL: The relationship of self-reported distress to psychopathology. J Consult Clinical Psycol 62:550-559, 1994
5. Herrman H, Patrick DL, Diehr P, et al: Longitudinal investigation of depression outcomes in primary care in six countries: The LIDO Study - Functional status, health service use and treatment of people with depressive symptoms. Psychol Med 32:889-902, 2002
6. Coyne JC, Palmer SC, Shapiro PJ, et al: Distress, psychiatric morbidity and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen Hosp Psychiatry 26:121-128, 2004
7. Babyak MA: What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 66:411-421, 2004
8. Ng TP, Niti M, Tan WC, et al: Depressive symptoms and chronic obstructive pulmonary disease: Effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167:60-67 2007
9. Drayer RA, Piraino B, Reynolds CF, et al: Characteristics of depression in hemodialysis patients: Symptoms, quality of life and mortality risk. Gen Hosp Psychiatry 28:306-312, 2006
10. Everson-Rose SA, House JS, Mero RP: Depressive symptoms and mortality risk in a national sample: Confounding effects of health status. Psychosom Med 66:823-830, 2004
11. Macleod J, Smith GD: Psychosocial factors and public health: A suitable case for treatment? J Epidem Commun Health 57:565-570, 2003